Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Short term Debt (2020 - 2026)

MDxHealth has reported Short term Debt over the past 7 years, most recently at $95.9 million for Q1 2026.

  • For Q1 2026, Short term Debt changed N/A year-over-year to $95.9 million; the TTM value through Mar 2026 reached $95.9 million, changed N/A, while the annual FY2025 figure was $76.2 million, 23417.59% up from the prior year.
  • Short term Debt was $95.9 million for Q1 2026 at MDxHealth, up from $76.2 million in the prior quarter.
  • Across five years, Short term Debt topped out at $95.9 million in Q1 2026 and bottomed at $324000.0 in Q4 2024.
  • The 5-year median for Short term Debt is $2.3 million (2022), against an average of $35.1 million.
  • Year-over-year, Short term Debt tumbled 72.37% in 2023 and then soared 23417.59% in 2025.
  • Over 5 years, Short term Debt stood at $2.3 million in 2022, then plummeted by 72.37% to $643000.0 in 2023, then tumbled by 49.61% to $324000.0 in 2024, then soared by 23417.59% to $76.2 million in 2025, then grew by 25.92% to $95.9 million in 2026.
  • The last three reported values for Short term Debt were $95.9 million (Q1 2026), $76.2 million (Q4 2025), and $324000.0 (Q4 2024) per Business Quant data.